Skip to content

Company

Lexeo Therapeutics

United States

The ETFs we cover that hold this company, and its latest news.

Which ETFs hold Lexeo Therapeutics?

Held by 41 covered funds. Sorted by Lexeo Therapeutics’ share of each fund. Holdings as of each fund’s latest SEC filing.

FundShare of fund
BBCVirtus LifeSci Biotech Clinical Trials0.6%
NOSGXSmall Cap Value Fund0.2%
XBIState Street(R) SPDR(R) S&P(R) Biotech0.1%
KOMPState Street(R) SPDR(R) S&P Kensho New Economies Composite0.1%
IWCiShares Micro-Cap0.1%
FSEVFidelity Enhanced Small Cap Value0.1%
VFMOVanguard U.S. Momentum Factor0.1%
FEACFidelity Enhanced U.S. All-Cap Equity0.0%
IBBQInvesco Nasdaq Biotechnology0.0%
QOWZInvesco Nasdaq Free Cash Flow Achievers0.0%
IBBiShares Biotechnology0.0%
VTWVVanguard Russell 2000 Value Index Fund0.0%
IWNiShares Russell 2000 Value0.0%
PWSPacer WealthShield0.0%
DFSCXU.S. Micro Cap Portfolio0.0%
IWMiShares Russell 20000.0%
NSIDXSmall Cap Index Fund0.0%
VTWOVanguard Russell 2000 Index Fund0.0%
RSSLGlobal X Russell 20000.0%
RESMColumbia Research Enhanced Small Cap0.0%
ITWOProShares Russell 2000 High Income0.0%
RBProShares Russell 2000 Dynamic Buffer0.0%
DFASDimensional U.S. Small Cap0.0%
FESMFidelity Enhanced Small Cap Core0.0%
PRFZInvesco Rafi US 1500 Small-Mid0.0%
SSMHXState Street Small/mid Cap Equity Index Portfolio0.0%
AVSCAvantis U.S. Small Cap Equity0.0%
VXFVanguard Extended Market Index Fund0.0%
DFACDimensional U.S. Core Equity 20.0%
MSSMMorgan Stanley Pathway Small-Mid Cap Equity0.0%
DXUVDimensional US Vector Equity0.0%
DFSUDimensional US Sustainability Core 10.0%
DFQTXU.S. Core Equity 2 Portfolio0.0%
IWViShares Russell 30000.0%
KCXSXKnights of Columbus U.S. ALL CAP INDEX FUND0.0%
VITPXVanguard Institutional Total Stock Market Index Fund0.0%
VTIVanguard Total Stock Market Index Fund0.0%
DFAUDimensional US Core Equity Market0.0%
ITOTiShares Core S&P Total U.S. Stock Market0.0%
VTHRVanguard Russell 3000 Index Fund0.0%
DFUSDimensional U.S. Equity Market0.0%

Where to buy these ETFs

[Affiliate and risk wording from the law firm]

Latest Lexeo Therapeutics news

No recent stories about Lexeo Therapeutics.